Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL/T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL

Goekbuget, Nicola and Fiedler, Walter and Alakel, Nael and Topp, Max S. and Hanoun, Maher and Steffen, Bjoern and Waesch, Ralph and Viardot, Andreas and Nachtkamp, Kathrin and Stelljes, Matthias and Poeck, Hendrik and Vucinic, Vladan and Boell, Boris and Beck, Joachim and Fransecky, Lars and Wendelin, Knut and Schneller, Folker and Faul, Christoph and Buecklein, Veit L. and Reiser, Lena and Brueggemann, Monika and Serve, Hubert and Schwartz, Stefan (2022) Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL/T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL. In: 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), December 10-13, 2022, New Orleans, LA.

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Speech)
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User:	Petra Gürster
Date Deposited:	05 Sep 2023 05:49
Last Modified:	05 Sep 2023 05:49
URI:	https://pred.uni-regensburg.de/id/eprint/58670

Actions (login required)

View Item